HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
36 hedge funds and large institutions have $88.7M invested in HOOKIPA Pharma in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 2 closing their positions.
320% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 5
79% more capital invested
Capital invested by funds: $49.7M → $88.7M (+$39M)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
3% more funds holding
Funds holding: 35 → 36 (+1)
0.29% more ownership
Funds ownership: 3.07% → 3.36% (+0.29%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.66M |
| 2 |
BlackRock
New York
|
+$2.48M |
| 3 |
State Street
Boston,
Massachusetts
|
+$581K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$421K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$346K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$1.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$914K |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$44.2K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$8.58K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
New York State Common Retirement Fund
Albany,
New York
| $53K | – | – | – |
|
27
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $44K | +$27K | +318 | +589% |
|
|
PCM
28
Prelude Capital Management
New York
| $32K | +$19.6K | +231 | +700% |
|
29
Legal & General Group
London,
United Kingdom
| $25K | +$17.6K | +207 | New |
|
30
Citigroup
New York
| $24K | +$16.1K | +190 | +1,900% |
|
31
BNP Paribas Financial Markets
Paris,
France
| $18.6K | +$12.1K | +142 | +1,420% |
|
32
Bank of Montreal
Toronto,
Ontario, Canada
| $15K | +$9.09K | +107 | +594% |
|
33
Wells Fargo
San Francisco,
California
| $12K | +$5.86K | +69 | +276% |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| $7K | +$1.53K | +18 | +45% |
|
|
AIP
35
Ameritas Investment Partners
Lincoln,
Nebraska
| $2K | – | – | – |
|
|
MAM
36
Meeder Asset Management
Dublin,
Ohio
| $2K | +$1.27K | +15 | New |
|
|
37
Victory Capital Management
San Antonio,
Texas
| – | -$8K | -109 | Closed |
|
|
SIC
38
Salem Investment Counselors
Winston Salem,
North Carolina
| – | -$7K | -90 | Closed |
|
HOOK Hedge Fund Activity: Q4 2019 in Review
36 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2019, worth a combined $88.7M — up 79% from $49.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new HOOK positions and 2 closed out — a net gain of 1 holder — while 21 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.66M. The largest seller was Artal Group, cutting an estimated $1.1M.
- 36 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2019, up from 35 in Q3 2019.
- Funds reported $88.7M of HOOKIPA Pharma stock for Q4 2019, up 79% quarter-over-quarter.
- 3 funds opened new HOOKIPA Pharma positions in Q4 2019 and 2 closed out, a net change of +1 holder.
- The largest HOOKIPA Pharma buyer in Q4 2019 was Vanguard Group, an estimated $2.66M added.
- The largest HOOKIPA Pharma seller in Q4 2019 was Artal Group, an estimated $1.1M sold.
Based on aggregated 13F filings for Q4 2019.